Skip to main content
Login
User menu
Mega menu
EASL.eu
Resources
Resources
EASL Resources
All Resources
Basic Techniques in Experimental Hepatology at a Glance
Clinical Practice Guidelines
Congress Resources
COVID-19 Resources
EASL Molecular Tumour Boards
EASL Genetic Grand Round
EASL Policy Dialogues
EASL Quiz
ePosters
EASL DeepDive
EASL Journal Club
Nurses and AHPs
Online Courses
On-demand Webinars
Podcasts
Slide Decks
Webcasts
Webinars Calendar
EASL-Related Resources
EHC On-demand Webinar
ERN Rare-Liver On-demand Webinars
Baveno VII - Consensus Workshop
Baveno VII - Pediatric Research Workshop
Industry Resources
All Resources
Industry Symposia - EASL Monothematic Conference 2023
Industry Symposia - EASL Congress
Industry Symposia - EASL Liver Cancer Summit
Industry Symposia - EASL SLD Summit
GSK Resources
Patient Resources
All Resources
COVID-19 Resources
Documents
ePosters
Infographics
Patient Guidelines
Podcasts
Slide Decks
Takeaways
Webcasts
EASL Studio
EASL Campus Connect
My Community
Explore Community
EASL Community Feed
All Topics
Community FAQ's
Create
Our Sponsors
Primary tabs
User menu
Resources 32
Session 32
(current)
Displaying 25 - 32 of 32
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
7
CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024
View
Immune-Mediated and Cholestatic Diseases
7
CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024
View
Immune-Mediated and Cholestatic Diseases
7
CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024
View
Immune-Mediated and Cholestatic Diseases
7
CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024
View
Immune-Mediated and Cholestatic Diseases
7
CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024
View
Immune-Mediated and Cholestatic Diseases
7
CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024
View
Immune-Mediated and Cholestatic Diseases
7
CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024
View
Immune-Mediated and Cholestatic Diseases
1
BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists - ILC 2022
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Page
2
Current page
3
Explore Community
Community Stream
Easl Community Feed
My Feed
Browse Stream
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy
